Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/bb/c6/bd/bbc6bd12-29e8-5ddd-8017-3f4de91c23af/mza_15042924640391451077.jpg/600x600bb.jpg
“Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with
CHED
11 episodes
2 weeks ago
Dr. David Benkeser talks about analyses of COVID-19 vaccine trials data on the immune response to those vaccines. We also discuss fluctuations in antibody levels and the potential for the trial data analyses to inform decisions on additional vaccine doses.
Show more...
Medicine
Health & Fitness
RSS
All content for “Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with is the property of CHED and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr. David Benkeser talks about analyses of COVID-19 vaccine trials data on the immune response to those vaccines. We also discuss fluctuations in antibody levels and the potential for the trial data analyses to inform decisions on additional vaccine doses.
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_episode/7877215/7877215-1626418542968-33666de236d31.jpg
“Going beyond the benchmarks: What it takes to get Americans vaccinated”: A conversation with Dr. Bob Bednarczyk about COVID-19 vaccine uptake.
“Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with
24 minutes 57 seconds
4 years ago
“Going beyond the benchmarks: What it takes to get Americans vaccinated”: A conversation with Dr. Bob Bednarczyk about COVID-19 vaccine uptake.

Dr. Bob Bednarczyk talks about COVID-19 vaccination efforts and inequities in vaccine uptake across the United States. We discuss reasons why certain communities are lagging behind vaccination goals and innovative approaches to increasing vaccination rates in those communities.

“Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with
Dr. David Benkeser talks about analyses of COVID-19 vaccine trials data on the immune response to those vaccines. We also discuss fluctuations in antibody levels and the potential for the trial data analyses to inform decisions on additional vaccine doses.